BioNexus Gene Lab Corp Common stock
$1.48
Market Cap
$4.34M
Shares Outstanding
2.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 11, 2020
Round Lot
100
Locale
US
Day Open
$1.57
Day High
$1.57
Day Low
$1.45
Volume
4.8K
VWAP
$1.49
Prev Close
$1.44
Transactions
--
Acc. Volume
--
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
BioNexus Gene Lab Corp Common stock (BGLC) closed the 2026-09-16 session at $1.48, up 2.78% versus the previous close (+0.04). The stock opened at $1.57 and traded between $1.45 and $1.57 during that session. Session trading volume was 5K shares. The volume-weighted average price (VWAP) is $1.49.
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.
BioNexus Gene Lab Corp Common stock has a market capitalization of $4.3 million. The company operates in the SERVICES-MEDICAL LABORATORIES industry classification. BGLC is listed on the XNAS exchange. The company employs approximately 1 people. The recorded listing date is 2020-03-11.
On this page you can find market BGLC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MEDICAL LABORATORIES sector.